Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals

The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study

(2013) Benjamin D. Parker   ANNALS OF INTERNAL MEDICINE

Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients

(2009) Heng Jung Hsu et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION

Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community-based cohort of men and women

(2009) Tommy Ahlström et al.   CLINICAL ENDOCRINOLOGY

Relationship between circulating FGF23 and total body atherosclerosis in the community

(2009) Majd A. I. Mirza et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients

(2009) G. Jean et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity

(2008) M. Mraz et al.   CLINICAL ENDOCRINOLOGY

Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

(2008) X. Zhang et al.   DIABETES

Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice

(2008) J. Xu et al.   DIABETES

Fibroblast Growth Factor 21 Corrects Obesity in Mice

(2008) Tamer Coskun et al.   ENDOCRINOLOGY

Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients

(2008) M. Wolf et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Vitamin D deficiency is the cause of common obesity

(2008) Y.J. Foss   MEDICAL HYPOTHESES

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease

(2008) A. Covic et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men

(2008) R. Marsell et al.   OSTEOPOROSIS INTERNATIONAL